Related Experiment Video
Updated: May 15, 2026
06:47
Microfluidics in Assessing Platelet Function
Published on: November 8, 2024
Platelet function monitoring and clopidogrel
Andrew R Harper1, Matthew J Price
1Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK. a.r.harper@ncl.ac.uk
Current Cardiology Reports
|December 20, 2012
Summary
Antiplatelet therapy using P2Y12 inhibitors like clopidogrel is crucial after percutaneous coronary intervention. Measuring platelet function may personalize therapy, but more trial data is needed to support routine use.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Dual antiplatelet therapy with aspirin and a P2Y12 receptor antagonist is standard after percutaneous coronary intervention (PCI) and for acute coronary syndrome (ACS).
- Individual variability in the antiplatelet effect of clopidogrel exists, with high on-treatment platelet reactivity linked to increased cardiovascular events post-PCI, including stent thrombosis.
Purpose of the Study:
- To explore the potential of incorporating platelet function testing into clinical practice.
- To assess if personalized antiplatelet therapy following PCI can be achieved through platelet function monitoring.
Main Methods:
- Review of existing literature on antiplatelet therapy and platelet function testing.
- Analysis of the association between high on-treatment platelet reactivity and cardiovascular events post-PCI.
Main Results:
- High on-treatment platelet reactivity is a significant risk factor for adverse cardiovascular outcomes after PCI.
- Ex vivo methods for measuring P2Y12 antagonist effects are clinically available.
Conclusions:
- Platelet function testing offers a potential strategy for tailoring antiplatelet therapy post-PCI.
- Definitive randomized trials are required to establish the routine use of platelet function testing in guiding antiplatelet therapy after PCI.
More Related Videos
Related Concept Videos
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
01:22Formation of the Platelet Plug
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
01:18Structure and Function of Platelets
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:30Venous Thrombosis IV: Nursing Management
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
01:30Pulse rhythm
Pulse rhythm refers to the pattern of pulsations within specific intervals, offering valuable insights into the regularity or irregularity of the heart's beats as observed through the pattern of pulsation within specific intervals. A regular pulse exhibits a consistent heart rate with uniform waveforms and pulsation force, variations of which can be classified as normal, weak, or bounding.
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac muscle...
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac muscle...